P3.09: Treatment with Tocilizumab Improves Arterial Function in Rheumatoid Arthritis: A 6-Months Pilot Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
P3.09: Treatment with Tocilizumab Improves Arterial Function in Rheumatoid Arthritis: A 6-Months Pilot Study ; volume:5 ; number:4 ; day:29 ; month:11 ; year:2011 ; pages:158-159 ; date:12.2011
Artery research ; 5, Heft 4 (29.11.2011), 158-159, 12.2011
- Classification
-
Medizin, Gesundheit
- Creator
-
Protogerou, A. D.
Zampeli, E.
Fragiadaki, K.
Stamatelopoulos, K.
Panopoulos, S.
Papamichael, C. M.
Sfikakis, P. P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1016/j.artres.2011.10.044
- URN
-
urn:nbn:de:101:1-2404291041009.482144161970
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Protogerou, A. D.
- Zampeli, E.
- Fragiadaki, K.
- Stamatelopoulos, K.
- Panopoulos, S.
- Papamichael, C. M.
- Sfikakis, P. P.
- SpringerLink (Online service)
Other Objects (12)
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Arterial calcification in rheumatoid arthritis
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Arterial calcification in rheumatoid arthritis
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Tocilizumab: A Review in Rheumatoid Arthritis
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Arterial calcification in rheumatoid arthritis
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT